KBG Corp, formerly Korea Bio-Gen Co Ltd, is a Korea-based company mainly engaged in silicone materials business. The Company manufactures and sells silicone materials such as silane monomers, silicone resins and polymers, and silicone fusion materials. The Company also produces and sell fine chemicals and bio products.

Employees

Sector

Specialty Chemicals

More about the company

Quotes

Date	Price	Change	Volume
26-08-19	₩2,805.00	-4.92%	13,626
26-08-18	₩2,950.00	-1.34%	18,354
26-08-14	₩2,990.00	+0.17%	6,227
26-08-13	₩2,985.00	-0.67%	9,770
26-08-12	₩3,005.00	+0.17%	6,730

End-of-day quote Korea S.E.

More quotes

Income Statement and Estimates

More financial data

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

End-of-day quote Korea S.E. 2026-08-19			5-day change	1st Jan Change
2,805.00 ^KRW	-4.92%		-6.66%	-36.25%

11-05	KBG Corp. announces Annual dividend, payable on April 10, 2026	CI
24-07-10	KBG Corp. completed the acquisition of Aerogel Korea Co. Ltd from TKG Taekwang CO.,LTD.	CI

Market Cap	24.4B 17.55M 15.06M 14.06M 12.9M 24.26M 1.68B 24.65M 166M 64.96M 841M 65.9M 64.47M 2.78B	P/E 2024	10.8x	P/E 2025	14.8x
Enterprise Value	7.66B 5.51M 4.73M 4.41M 4.05M 7.62M 527M 7.74M 52.1M 20.4M 264M 20.7M 20.25M 874M	EV / Sales 2024	1.22x	EV / Sales 2025	0.9x
Free-Float	63.58%	Yield 2024 *	-	Yield 2025	-

11-05	KBG Corp. announces Annual dividend, payable on April 10, 2026	CI
24-07-10	KBG Corp. completed the acquisition of Aerogel Korea Co. Ltd from TKG Taekwang CO.,LTD.	CI
24-06-27	KBG Corp. agreed to acquire Aerogel Korea Co. Ltd from TKG Taekwang CO.,LTD for KRW 8.3 billion.	CI
23-05-12	KBG Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
21-05-11	Korea Bio-Gen Co.,Ltd announced that it has received KRW 5 billion in funding from Daegyeong Investment Co., Ltd. and another investor	CI
21-05-09	Korea Bio-Gen Co.,Ltd announced that it expects to receive KRW 5 billion in funding from Daegyeong Investment Co., Ltd. and another investor	CI
20-09-16	Tranche Update on Korea Bio-Gen Co.,Ltd's Equity Buyback Plan announced on March 17, 2020.	CI
20-09-16	Tranche Update on Korea Bio-Gen Co.,Ltd's Equity Buyback Plan announced on March 17, 2020.	CI
20-09-15	Korea Bio-Gen Co.,Ltd's Equity Buyback announced on March 17, 2020, has expired with 79,364 shares, representing 0.98% for KRW 318.89 million.	CI
20-06-17	Tranche Update on Korea Bio-Gen Co.,Ltd's Equity Buyback Plan announced on March 17, 2020.	CI
20-03-16	Korea Bio-Gen Co.,Ltd announces an Equity Buyback for KRW 2,000 million worth of its shares.	CI
20-03-16	Korea Bio-Gen Co.,Ltd authorizes a Buyback Plan.	CI
19-07-30	Korea Bio-Gen Co.,Ltd has completed an IPO in the amount of KRW 10.707 billion.	CI

1 day	-4.92%
1 week	-6.66%
Current month	+2.19%
1 month	-4.10%
3 months	-28.08%
6 months	-35.96%
Current year	-36.25%

KBG Corp. Stock

Stocks

A318000

KR7318000007

Specialty Chemicals

Valuation: KBG Corp.

Chart: KBG Corp.

Latest news : KBG Corp.

Quotes and Performance

Course Extremes

Managers and Directors: KBG Corp.

Other Specialty Chemicals

Financials

Company Profile

Quotes

Income Statement and Estimates

1 week	2,800	3,070
1 month	2,545	3,100
Current year	2,545	4,830
1 year	2,545	6,160
3 years	2,545	14,340
5 years	2,545	21,150
10 years	2,545	21,150

Manager	Title	Age	Since
Sam-Yeol Pu CEO	Chief Executive Officer	40	2022-03-23
Tae-Kyun Boo SAM	Sales & Marketing	60	2020-02-29
Sang-Ho Do AUD	Comptroller/Controller/Auditor	67	-

Director	Title	Age	Since
Tae-Ung Pu CHM	Chairman	68	-
Sam-Yeol Pu BRD	Director/Board Member	40	2022-03-23
Kyung Choi BRD	Director/Board Member	68	2024-03-24

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
KBG CORP.	-4.92%	-6.66%	-44.23%	-76.72%	17.55M
ECOLAB INC.	+2.01%	+2.58%	+0.69%	+59.25%	80.07B
SIKA AG	-1.69%	-4.63%	-4.45%	-25.56%	37.09B
GIVAUDAN SA	+1.03%	-1.01%	-6.71%	+17.81%	36.8B
FUJIFILM HOLDINGS CORPORATION	+2.61%	-1.74%	-9.65%	+18.17%	23.67B
EMS-CHEMIE HOLDING AG	-0.51%	-2.39%	+24.10%	+18.77%	22.73B
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.	+1.22%	+5.80%	+67.33%	+18.80%	21.53B
DUPONT DE NEMOURS, INC.	+0.63%	-3.25%	-36.89%	-38.25%	18.86B
ALBEMARLE CORPORATION	+1.18%	+4.63%	+66.70%	-26.78%	15.85B
NITTO DENKO CORPORATION	+2.38%	-3.15%	+4.75%	+77.34%	14.08B
Average	+0.40%	-1.39%	+6.16%	+4.28%	27.07B
Weighted average by Cap.	+1.03%	-0.33%	+6.80%	+20.89%

	2024	2025
Net sales	24.92B 17.92M 15.37M 14.35M 13.17M 24.77M 1.71B 25.17M 169M 66.33M 859M 67.29M 65.83M 2.84B	23.92B 17.21M 14.76M 13.78M 12.64M 23.78M 1.64B 24.17M 163M 63.68M 825M 64.6M 63.2M 2.73B
Net income	3.77B 2.71M 2.32M 2.17M 1.99M 3.74M 259M 3.81M 25.6M 10.03M 130M 10.17M 9.95M 429M	2.59B 1.86M 1.6M 1.49M 1.37M 2.58M 178M 2.62M 17.62M 6.9M 89.37M 7M 6.85M 295M
Net Debt	-10.55B -7.59M -6.51M -6.08M -5.58M -10.49M -726M -10.66M -71.75M -28.1M -364M -28.51M -27.89M -1.2B	-16.74B -12.04M -10.33M -9.64M -8.85M -16.64M -1.15B -16.91M -114M -44.56M -577M -45.21M -44.22M -1.91B